Hyundai Pharmaceutical Co., Ltd. (KRX:004310)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,020
+670 (5.90%)
Jan 30, 2026, 3:30 PM KST
245.90%
Market Cap332.69B +231.6%
Revenue (ttm)108.14B +5.8%
Net Income1.41B
EPS60.34
Shares Out27.68M
PE Ratio199.21
Forward PEn/a
Dividend30.00 (0.26%)
Ex-Dividend DateMar 4, 2025
Volume3,963,625
Average Volume3,726,071
Open11,250
Previous Close11,350
Day's Range11,060 - 13,150
52-Week Range2,995 - 14,700
Beta0.55
RSI63.69
Earnings Daten/a

About Hyundai Pharmaceutical

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive sy... [Read more]

Sector Healthcare
Founded 1965
Employees 393
Stock Exchange Korea Stock Exchange
Ticker Symbol 004310
Full Company Profile

Financial Performance

Financial Statements